This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Reliant Pharmaceuticals (sells ethical pharmaceuticals in primary care and specialty markets) closed a Series D private placement of convertible preferred units in which it raised $78mm. Several previous investors also exchanged secured debt, worth $37mm, for the units. Invemed Catalyst Fund led the round, followed by Bay City Capital Fund III, the Pritzker family businesses, BayStar Capital, and Reliant chairman and CEO Ernest Mario's family interests.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?